Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its subsidiary Changchun...
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276, HKG: 1276) announced it has received separate clinical...
Astellas Pharma Inc. (TYO: 4503) has unveiled its Corporate Strategic Plan 2026 (CSP2026), a comprehensive...
The Global Medical Device Training, Exhibition, Trading and Innovation Center was officially inaugurated this week...
Shanghai Henlius Biotech Inc. (HKG: 2696) announced the dosing of the first patient in a...
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276, HKG: 1276) and its U.S. partner Kailera Therapeutics...
Insilico Medicine (HKG: 3696) and Human Life Foundation Models (HLFM), a newly established spin-off from...
Shanghai Henlius Biotech Inc. (HKG: 2696) announced the dosing of the first patient in China...
Eli Lilly and Company (NYSE: LLY) announced strategic agreements to acquire Curevo Inc., LimmaTech Biologics...
Shanghai Simpletouch Robot Co., Ltd. has filed its prospectus with the Hong Kong Stock Exchange...
Qingfeng Pharmaceutical Group Co., Ltd. announced a licensing agreement with Merz Therapeutics GmbH, a German...
Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that the National Medical...
China Medical System Holdings Limited (CMS, HKG: 0867) announced it has received clinical trial authorization...
MicroPort NeuroTech Limited (HKG: 2172) announced it has received marketing approval from the U.S. Food...
Eli Lilly and Company (NYSE: LLY) announced positive interim results from the Phase 1b Heart-2...
Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic...
Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA: 603567) announced a strategic agent marketing agreement with fellow...
Pierre Fabre Laboratories announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
OTR Therapeutics announced that China’s National Medical Products Administration (NMPA) has granted approval to initiate...